NYSE:CGC - Canopy Growth Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $43.27 -1.34 (-3.00 %) (As of 05/21/2019 08:48 AM ET)Previous Close$44.61Today's Range$43.02 - $44.2752-Week Range$24.21 - $59.25Volume2.62 million shsAverage Volume8.09 million shsMarket Capitalization$14.89 billionP/E RatioN/ADividend YieldN/ABeta4.17 ProfileAnalyst RatingsChartEarningsInstitutional OwnershipHeadlinesOptions ChainSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, Bedrocan Canada, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada to investigate the efficacy of cannabinoids for the treatment of post-concussion neurological diseases in former NHL players. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada. Receive CGC News and Ratings via Email Sign-up to receive the latest news and ratings for CGC and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Medicinals & botanicals Sub-IndustryCannabis SectorMedical Current SymbolNYSE:CGC Previous Symbol CUSIPN/A CIKN/A Webwww.canopygrowth.com Phone855-558-9333Debt Debt-to-Equity Ratio0.10 Current Ratio17.85 Quick Ratio17.12Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$60.79 million Price / Sales244.95 Cash FlowN/A Price / Cash FlowN/A Book Value$4.87 per share Price / Book8.89Profitability EPS (Most Recent Fiscal Year)($0.32) Net Income$-54,880,000.00 Net Margins-267.40% Return on Equity-14.39% Return on Assets-11.12%Miscellaneous Employees1,033 Outstanding Shares344,135,000Market Cap$14.89 billion Next Earnings Date6/26/2019 (Estimated) OptionableOptionable Canopy Growth (NYSE:CGC) Frequently Asked Questions What is Canopy Growth's stock symbol? Canopy Growth trades on the New York Stock Exchange (NYSE) under the ticker symbol "CGC." When is Canopy Growth's next earnings date? Canopy Growth is scheduled to release their next quarterly earnings announcement on Wednesday, June 26th 2019. View Earnings Estimates for Canopy Growth. What price target have analysts set for CGC? 11 brokerages have issued 1 year target prices for Canopy Growth's stock. Their forecasts range from $46.27 to $80.00. On average, they anticipate Canopy Growth's stock price to reach $64.8175 in the next twelve months. This suggests a possible upside of 49.8% from the stock's current price. View Analyst Price Targets for Canopy Growth. What is the consensus analysts' recommendation for Canopy Growth? 11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Canopy Growth. Has Canopy Growth been receiving favorable news coverage? Headlines about CGC stock have trended somewhat negative this week, according to InfoTrie Sentiment. The research firm rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Canopy Growth earned a coverage optimism score of -1.1 on InfoTrie's scale. They also gave media stories about the marijuana producer a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the company's share price in the near future. Who are some of Canopy Growth's key competitors? Some companies that are related to Canopy Growth include Aurora Cannabis (ACB), Cronos Group (CRON), Tilray (TLRY), USANA Health Sciences (USNA), CV Sciences (CVSI), Chromadex (CDXC), Canopy Rivers (RIV), Foamix Pharmaceuticals (FOMX), Mediwound (MDWD), Natural Alternatives International (NAII), Mannatech (MTEX), China Jo-Jo Drugstores (CJJD), Cyanotech (CYAN), FitLife Brands (FTLF) and GLG Life Tech (GLGLF). What other stocks do shareholders of Canopy Growth own? Based on aggregate information from My MarketBeat watchlists, some companies that other Canopy Growth investors own include NVIDIA (NVDA), Alibaba Group (BABA), Micron Technology (MU), General Electric (GE), Aurora Cannabis (ACB), Cronos Group (CRON), Canopy Growth (WEED), KushCo (KSHB), Aurora Cannabis (ACBFF) and Aurora Cannabis (ACB). Who are Canopy Growth's key executives? Canopy Growth's management team includes the folowing people: Mr. Bruce A. Linton, Co-Founder, Chairman & Co-CEO (Age 52)Mr. Mark Anthony Nicholas Zekulin, Pres & Co-CEOMr. Timothy Rob Saunders, Exec. VP & CFOMr. Rade Kovacevic, Exec. VPMs. Ann Gordon, VP of Corp. Fin. Who are Canopy Growth's major shareholders? Canopy Growth's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Morgan Stanley (0.57%), AQR Capital Management LLC (0.35%), Connor Clark & Lunn Investment Management Ltd. (0.24%), Sumitomo Mitsui Trust Holdings Inc. (0.24%), TD Asset Management Inc. (0.22%) and Swiss National Bank (0.21%). Which institutional investors are selling Canopy Growth stock? CGC stock was sold by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., Connor Clark & Lunn Investment Management Ltd., FIL Ltd, CIBC World Markets Inc., The Manufacturers Life Insurance Company , Victory Capital Management Inc., TD Asset Management Inc. and Jefferies Group LLC. Which institutional investors are buying Canopy Growth stock? CGC stock was bought by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Janus Henderson Group PLC, Morgan Stanley, Toronto Dominion Bank, Essex Investment Management Co. LLC, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Sumitomo Mitsui Trust Holdings Inc. and Cambridge Investment Research Advisors Inc.. How do I buy shares of Canopy Growth? Shares of CGC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Canopy Growth's stock price today? One share of CGC stock can currently be purchased for approximately $43.27. How big of a company is Canopy Growth? Canopy Growth has a market capitalization of $14.89 billion and generates $60.79 million in revenue each year. The marijuana producer earns $-54,880,000.00 in net income (profit) each year or ($0.32) on an earnings per share basis. Canopy Growth employs 1,033 workers across the globe. What is Canopy Growth's official website? The official website for Canopy Growth is http://www.canopygrowth.com. How can I contact Canopy Growth? Canopy Growth's mailing address is 1 HERSHEY DRIVE, SMITH FALLS A6, K7A0A8. The marijuana producer can be reached via phone at 855-558-9333 or via email at [email protected] MarketBeat Community Rating for Canopy Growth (NYSE CGC)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 346 (Vote Outperform)Underperform Votes: 329 (Vote Underperform)Total Votes: 675MarketBeat's community ratings are surveys of what our community members think about Canopy Growth and other stocks. Vote "Outperform" if you believe CGC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CGC will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/21/2019 by MarketBeat.com StaffFeatured Article: Differences Between Momentum Investing and Long Term Investing Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.